Pregnant Women Erythromycin treatment of screened women leads to some improved perinatal and postnatal outcomes for children. Fair evidence to support screening and treating pregnant women. Fair evidence to support screening of high-risk groups.
Treatment is effective in eliminating chlamydia.
No studies show that screening leads to reduction of complications. Economic evaluation studies suggest that screening high-risk populations may prevent symptoms and reduce overall cost of infection. General Population Available screening tests are accurate and reliable but have poor positive predictive value and economic viability when prevalence is low. There have been no studies demonstrating that screening and early detection leads to reduction in complications. Fair evidence to support exclusion of routine screening in the general population.